BAJAJ BROKING
Wockhardt Ltd’s Miqnaf (nafithromycin), approved by CDSCO for CABP, is an ultra-short course antibiotic targeting drug-resistant pathogens. Despite the news, Wockhardt share price declined by 0.88%.
Pharmaceutical company Wockhardt Ltd has received approval from the Central Drugs Standard Control Organization (CDSCO) for Miqnaf (nafithromycin), a novel treatment for Community-Acquired Bacterial Pneumonia (CABP) in adults. The antibiotic offers an ultra-short course regimen of once-a-day dosage for three days, targeting multi-drug resistant (MDR) pathogens.
Also read: Biocon Gets China NMPA Approval for Tacrolimus Capsules
Innovative Regimen: Ultra-short, three-day course for improved patient compliance.
Target Pathogens: Effective against MDR bacteria like S. pneumoniae and H. influenzae.
Clinical Trials: Tested in the US, Europe, South Africa, and India.
India’s Disease Burden: India accounts for 23% of global CABP cases.
Also read: Avenue Supermarts Reports 17.5% Revenue Growth in Q3 FY25
Miqnaf is the first macrolide-based antibiotic introduced in India in nearly 30 years, addressing a critical gap in CABP treatment. It is designed to combat antibiotic-resistant strains, reducing the need for hospitalisation in severe cases. This aligns with efforts to mitigate India’s growing antibiotic resistance crisis, which significantly impacts the treatment of respiratory infections.
Feature | Details |
Treatment Duration | 3 days, once daily |
Target Pathogens | MDR strains, including S. pneumoniae |
Clinical Studies | Conducted across US, Europe, and India |
Disease Focus | CABP and other respiratory infections |
Wockhardt plans to launch Miqnaf in the Indian market within a few months. With India bearing a significant global disease burden for CABP, Miqnaf is expected to play a pivotal role in improving treatment outcomes.
The approval of Miqnaf signifies a significant advancement in CABP treatment, addressing antibiotic resistance and improving compliance. Despite this milestone, Wockhardt share price declined by 0.88%, closing at ₹1,445.75.
Also read: IRFC Partners REMCL to Fund Renewable Energy for Railways
Do you have a trading account app or demat account app?
You can open an account with Bajaj Broking in minutes.
Download the Bajaj Broking app now from Play Store or App Store.
Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.
This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For All Disclaimers Click Here: https://bit.ly/3Tcsfuc
Share this article:
PPF vs Mutual Fund Investment: Which is Better for You?
04 Jan, 2025 | 7 Min. read
How to Apply for Standard Glass Lining IPO & Check Allotment Status?
04 Jan, 2025 | 1 Min. read
How to Apply for Indobell Insulations IPO & Check Allotment Status?
04 Jan, 2025 | 1 Min. read
Know the Objective & Analysis of Indobell Insulations IPO
04 Jan, 2025 | 3 Min. read
Reasons for Missing Out on an IPO Allotment
04 Jan, 2025 | 7 Min. read
IPO Performance in India - List of Successful IPOs in 2024
04 Jan, 2025 | 3 Min. read
Quadrant Future Tek IPO- Key Objective & Deep Analysis
04 Jan, 2025 | 3 Min. read
Gold Price in India | Gold Rises 1.2% to $2,671.50; Silver Gains 2.6%
03 Jan, 2025 | 40 Min. read
Avenue Supermarts Reports 17.5% Revenue Growth in Q3 FY25
03 Jan, 2025 | 2 Min. read
What’s the Minimum Amount for Mutual Fund Investments?
03 Jan, 2025 | 6 Min. read
Biocon Gets China NMPA Approval for Tacrolimus Capsules
03 Jan, 2025 | 2 Min. read
Wockhardt’s Miqnaf Gains CDSCO Approval for CABP Treatment
03 Jan, 2025 | 2 Min. read
RBI Launches ULI: Transforming Loan Access
August 27, 2024 | 4 Min. read
Textile Sector in India
September 20, 2024 | 5 Min. read
List of IPOs with DRHPs Filed
November 30, 2023 | 3 Min. read
Aditya Birla Group
September 28, 2023 | 10 Min. read
Bajaj Housing Finance Ltd IPO: Things Smart Investors Need to Know
September 05, 2024 | 4 Min. read
Budget Stock Ideas 2024-2025 | Stocks to Buy Today
July 24, 2024 | 4 Min. read
IPO Eligibility Criteria : Full Details
March 15, 2024 | 6 Min. read
What Is the Lock-In Period in IPOs?
October 18, 2023 | 6 Min. read
Godfrey Phillips Announces 2:1 Bonus Shares
September 16, 2024 | 7 Min. read
Jindal Group- A Comprehensive Analysis
September 27, 2024 | 7 Min. read
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading